Ginkgolic acid C17:1


CAS No. : 111047-30-4

111047-30-4
Price and Availability of CAS No. : 111047-30-4
Size Price Stock
5mg $269 In-stock
10mg $457 In-stock
50 mg Get quote
100 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-N2116
M.Wt: 374.56
Formula: C24H38O3
Purity: >98 %
Solubility: DMSO : 100 mg/mL (ultrasonic)
Introduction of 111047-30-4 :

Ginkgolic acid C17:1 is a fatty acid synthase (FAS) inhibitor with an IC50 of 10.5 µM. Ginkgolic acid C17:1 shows anti-tumor activity by inhibiting the phosphorylation of STAT3 and inducing apoptosis. Ginkgolic acid C17:1 can block the interaction between S-RBD and ACE2, and has anti-SARS-CoV-2-S pseudovirus activity. Ginkgolic acid C17:1 inhibits the biofilm formation of enterohemorrhagic Escherichia coli and Staphylococcus aureus[1][2][3][4][5]. IC50 & Target:PTEN; Phosphatase[1] In Vitro: Ginkgolic acid C17:1 (30-50 μM; 24 h) reduces the viability of U266 cells with an IC50 about 64 µM, but has no effect on PBMCs[1].
Ginkgolic acid C17:1 (30-50 μM; 1.5-24 h) inhibits the phosphorylation of STAT3, up-regulates the expression of PTEN and SHP-1, and induces apoptosis in multiple myeloma cells[1].
Ginkgolic acid C17:1 (10-500 μM; 25 h) inhibits SARS-CoV-2-S pseudovirus in hACE2/HEK293T cells with an IC50 of 79.43 μM and the maximum half cytotoxic concentration (CC50) of 130.8 μM[2].
Ginkgolic acid C17:1 (1-20 μg/mL; 24 h) significantly and dose-dependent inhibits the biofilm formation of enterohemorrhagic Escherichia coli (EHEC) and Staphylococcus aureus, but did not affect the growth of EHEC cells[3].
Ginkgolic acid C17:1 (0-30 μg/mL; 0-72 h) inhibits SMMC-7721 cells with an IC50 of 8.5 μg/mL, and induces apoptosis and inhibits cell migration[4].

Your information is safe with us.